Novartis Foundation

We’re not your usual type of foundation! ☝️ Check out our three core initiatives harnessing novel technologies and data to improve the health and wellbeing of populations around the globe. Curious to learn more? Make sure to follow us to not miss any updates as we work toward narrowing the health equity gap! #PopulationHealth #HealthEquity #HealthData

With rapid urbanization and an ever-increasing pressure on health systems, it is cities we have to turn to in our quest toward greater population health.   Acknowledging the need for novel solutions to a persistent problem, the Novartis Foundation and its partners have set out to identify the mechanisms behind unequal health outcomes. Leveraging artificial intelligence and advanced analytics, our population health approach 𝐀𝐈4𝐇𝐞𝐚𝐥𝐭𝐡𝐲𝐂𝐢𝐭𝐢𝐞𝐬 brings together hitherto disconnected data sets from the health sector and beyond to decipher the hidden, everyday drivers of heart health in urban areas.   Juha Jolkkonen, Executive Director of Social Services, Health Care and Rescue Services Division at the city of Helsinki and a member of our 𝐀𝐈4𝐇𝐞𝐚𝐥𝐭𝐡𝐲𝐂𝐢𝐭𝐢𝐞𝐬 Global Expert Council explains what role cities can play in fostering better health at population level, what is needed and the challenges their inhabitants are facing today.   For the first time, the Novartis Foundation will reveal early AI-enabled insights on the drivers of heart health outcomes in 𝐍𝐞𝐰 𝐘𝐨𝐫𝐤 𝐂𝐢𝐭𝐲 𝐨𝐧 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 24. Learn more and sign up for in-person attendance here: https://bit.ly/4dAklVE   #AI4HealthyCities #PopulationHealth #HealthEquity Helsingin kaupunki – Helsingfors stad – City of Helsinki

𝐄𝐧𝐭𝐞𝐫 𝐚 𝐧𝐞𝐰 𝐞𝐫𝐚 𝐨𝐟 𝐩𝐫𝐞𝐜𝐢𝐬𝐢𝐨𝐧 𝐩𝐨𝐩𝐮𝐥𝐚𝐭𝐢𝐨𝐧 𝐡𝐞𝐚𝐥𝐭𝐡 𝐰𝐢𝐭𝐡 𝐮𝐬 - j𝐨𝐢𝐧 𝐨𝐮𝐫 𝐞𝐯𝐞𝐧𝐭 𝐢𝐧 𝐍𝐞𝐰 𝐘𝐨𝐫𝐤 𝐨𝐧 𝐒𝐞𝐩𝐭𝐞𝐦𝐛𝐞𝐫 24! During the 79th United Nations Global Assembly, we will reveal early insights from our 𝐀𝐈4𝐇𝐞𝐚𝐥𝐭𝐡𝐲𝐂𝐢𝐭𝐢𝐞𝐬 population health initiative and outline what factors determine people’s heart health in cities like New York City and Singapore. Together with Foreign Policy and esteemed guest speakers, we will discuss how health authorities and providers, as well as innovators, researchers, and urban planners can leverage these insights to create local precision population health roadmaps to effectively reduce cardiovascular health inequities in their communities. ✅ 𝐑𝐞𝐠𝐢𝐬𝐭𝐞𝐫 𝐧𝐨𝐰, seats are limited: https://lnkd.in/dmz2Jh6s ⏰ When: September 24, 12.30 PM EDT (Doors open at 12:00 PM EDT for lunch) 📍 Where: The Westin New York Grand Central, Madison Ballroom #PopulationHealth #HealthEquity #UNGA79

New publication! 📰 🏥 Primary care management improvement 🗺 Patient pathway optimization 👨⚕️👩⚕️ Workforce up-skilling The Novartis Foundation identified these three areas as key elements for generating sustainable impact in cardiovascular population health based on a survey of patients, health care professionals and health system representatives in São Paulo, Brazil. As a consequence, a package of solutions was designed, promptly taken up and deployed by the municipal health secretariat, yielding exceptional results. This package of solutions is now already being implemented in other Brazilian cities, and available for all cities in the region interested to implement the successful 𝐂𝐀𝐑𝐃𝐈𝐎4𝐂𝐢𝐭𝐢𝐞𝐬 approach to improve the heart health of their populations. Access the full paper for free now: https://bit.ly/4cJeL30 #CardiovascularDisease #PopulationHealth #Publication

“We are proud of the pioneering collaboration we were able to build with the Ministry of Health of Senegal and its NCD Division to tackle hypertension and cardiovascular disease in Senegal.’ Last week, Sarah Des Rosiers, our Director for Health Equity, participated in the handover ceremony of the 𝐂𝐀𝐑𝐃𝐈𝐎4𝐃𝐚𝐤𝐚𝐫 initiative, a rich session that acknowledged the major achievements realized over the last 6 years by the Ministry of Health of Senegal and the Novartis Foundation’s implementing partner, IntraHealth International, to fight the growing burden of hypertension and CVDs. 𝐂𝐀𝐑𝐃𝐈𝐎4𝐃𝐚𝐤𝐚𝐫 was initiated in 2018 with the goal to address the growing hypertension burden in the population of Dakar. Today the prevalence of hypertension is at 30%, with almost 1 in 3 adults affected. The initiative’s aim was to improve its early detection in the communities, strengthen the quality of care from diagnosis to care and treatment, and strengthen the collection of data and its integration into the health information system for better decision-making. Under the leadership of Dr. Malick Anne, Chief of the NCD Division and with the presence of Cheikh Touré, the West African Regional Director of IntraHealth and a representative of the health Dpt of the Mairie de Dakar, participants reviewed the major resulted and tools co-created by this initiative. We would like to thank the Ministère de la Santé et de l'Action Sociale (MSAS) and its NCD Division for the tireless work, IntraHealth for their continual engagement and technical expertise, and to all of the health care and tech players who have made 𝐂𝐀𝐑𝐃𝐈𝐎4𝐃𝐚𝐤𝐚𝐫 a reality. With all of the interventions fully embedded in the activities of the MSAS, we are confident that the actions will continue for a durable success. The Novartis Foundation was one of the first funders in the NCDs space in Senegal and we are pleased to see that new players are making hypertension and CVDs a priority – such as JICA, AMREF and PATH. However, we call for more global attention and the urgent need for larger scale funding to address CVDs in the global south. Learn more about our work: www.novartisfoundation.org Dr Malick ANNE | Seynabou Mbow | Cheikh Abdoulaye T. | Joseph Silva BARBOZA | 𝐀𝐰𝐚 𝐌𝐚𝐫𝐢𝐞 𝐂𝐨𝐥𝐥 𝐒𝐞𝐜𝐤 | 𝐌𝐢𝐧𝐢𝐬𝐭è𝐫𝐞 𝐝𝐞 𝐥𝐚 𝐒𝐚𝐧𝐭é 𝐞𝐭 𝐝𝐞 𝐥'𝐀𝐜𝐭𝐢𝐨𝐧 𝐒𝐨𝐜𝐢𝐚𝐥𝐞 | BAAMTU TECHNOLOGIES | By Filling Agency | Novartis | Novartis Global Health | Swiss Tropical and Public Health Institute | PATH #CardiovascularDisease | #Hypertension | #PopulationHealth

“At the Novartis Foundation, we firmly believe in the power of data, technology and AI to open new avenues of how we deliver health and care for entire populations.” Last week, Sarah Des Rosiers, our Director for Health Equity, participated in an insightful panel discussion at the 2024 𝐀𝐟𝐫𝐢𝐜𝐚 𝐁𝐮𝐬𝐢𝐧𝐞𝐬𝐬 𝐃𝐚𝐲 about the promise that digital technologies hold for our health, and how to unfold their full potential. Sarah shared examples from across our programmatic pillars with the audience, including how the HealthTech Hub Africa supports African start-ups and scale-ups in bringing their health tech solutions to the market, as well as how we leverage data and AI to decipher the true drivers behind cardiovascular population health as part of our 𝐀𝐈4𝐇𝐞𝐚𝐥𝐭𝐡𝐲𝐂𝐢𝐭𝐢𝐞𝐬 initiative. Learn more about our work: www.novartisfoundation.org Many thanks to all panelists for the great discussion! Spring Gombe | Tzippy Yanai | Khalil Kadaoui | Hadj Latreche | Swiss-African Business Circle | African Export-Import Bank (Afreximbank) | Novartis | Novartis Global Health | #ABD24 | #AfricaBusinessDay | #PopulationHealth

We are hiring! 📢 Are you an MD with a knack for precision medicine, health data and advanced analytics? Join our team on its way to transforming reactive care systems into proactive, predictive and ultimately true health systems keeping people healthy. Apply now! #Hiring #JobOpportunity #PopulationHealth

Brazil, here comes your heart health boost! ❤️ Too many lives lost too early: for the past decades, cardiovascular disease has been weighing heavily on South America’s biggest country. What used to be a burden for individuals had turned into a massive problem for an entire nation. That needed changing. Since 2017, under the leadership of the health authorities of city of São Paulo, the Novartis Foundation has successfully collaborated with a coalition of local partners to uncover and better manage risk factors for heart health. While implementing our CARDIO4Cities population health approach, nine validated solutions across the public health system’s cascade of care were deployed to lower the cardiovascular risk burden for city inhabitants. Seven years down the road and after touching millions of lives, we are excited to enter a new era of heart health for Brazil. We are proud to announce that yesterday, as part of a small ceremony, the BP - A Beneficência Portuguesa de São Paulo, one of Brazil’s leading excellence clusters in hospital care, population health and cardiology, was officially onboarded as collaboration partner and future execution lead for the initiative in São Paulo. This new partnership is a hallmark of our commitment to generating sustainable local impact and long-term health system strengthening. At the same time, and after already having replicated the program in two other Brazilian municipalities, this milestone is a springboard for the further national scaling of CARDIO, as the Beneficência Portuguesa de São Paulo brings powerful catalytic capabilities needed to move the needle on heart health. We are utmost grateful to our partners who share in our mission to alleviate the burden of cardiovascular disease for millions of people! Muito obrigado pelas parceiras de impacto, inovações pragmáticas e a paixão que muda vidas! Secretaria Municipal da Saúde de São Paulo Grupo Tellus Umane SOCESP - SOCIEDADE DE CARDIOLOGIA DO ESTADO DE SÃO PAULO Swiss Re Fórum Intersetorial de CCNTs no Brasil Schweizerisches Tropen- und Public Health-Institut American Heart Association IQVIA #CARDIO4Cities #CuidandoDeTodos

The only way forward is together ❤ A whole-of-city approach to resolve the enormous challenge of cardiovascular health and care takes mainly one thing to be successful: strong partners sharing in your mission. We are immensely grateful to Jean-Luc Eiselé and the World Heart Federation for officially becoming the scientific partner of our 𝐂𝐀𝐑𝐃𝐈𝐎4𝐂𝐢𝐭𝐢𝐞𝐬 𝐀𝐜𝐜𝐞𝐥𝐞𝐫𝐚𝐭𝐨𝐫, propelling evidence-based population health roadmaps forward. During our joint #WHA77 event, internationally leading experts in public health and cardiovascular disease shared their unique insights with our audience. Unanimously agreeing that health is more than healthcare, they deemed reliable and comprehensive data sets from within and beyond the health sector a crucial resource for better decision making and sustainable improvements in health and care. Special thanks to: Professor The Hon Greg Hunt Michelle Williams Jagat Narula MD PhD Dr. Ashwin Vasan Mohamed H. Al-Thani Lilian Mbau, MD, MPH, MSc (Prev. Cardio), CRFC Stephen Nicholls Patricia Duetsch Shiulie Ghosh A recording of the event will be shared shortly. Until then, Learn more about the CARDIO4Cities Accelerator here: https://bit.ly/3O1mX59 #PopulationHealth #HealthEquity #CardiovascularDisease

I could not have had a better start to the 2024 World Health Assembly in Geneva than attending the #WorldHeartSummit by the World Heart Federation! I had the tremendous pleasure to form a panel together with the brilliant minds of Jagat Narula MD PhD (President elect, World Heart Federation) and Pablo Perel (Lead Scientist, World Heart Federation), where we spoke about the importance of deploying population health interventions to tackle the ever-growing burden of cardiovascular disease. We agreed that 𝐂𝐀𝐑𝐃𝐈𝐎4𝐂𝐢𝐭𝐢𝐞𝐬, the Novartis Foundation’s population health approach, is a powerful and effective way to alleviate the burden of heart disease through real-time data evidence and precise risk factor management. Thank you for championing heart health around the globe, dear World Heart Federation! ❤️ There is more to come on how the World Heart Federation and the Novartis Foundation will collaborate to elevate heart health at scale – stay tuned. And for those in Geneva this week: I invite you to attend our joint event on May 29. More details can be found here: https://bit.ly/44EdO9t #UseHeart #WHA77 Andrea Vassalotti | Jean-Luc Eiselé | Aldina Aljukić | Elizabeth Adamson | Sarah Des Rosiers